| 期刊論文| 1. | The National Institute of Neurological Disorders and Stroke rt-PA Stroke study Group(1995)。Tissue plasminogen activator for acute ischemic stroke。New England Journal Medicine，333，1581-1587。   | | 2. | Hacke, W.、Kaste, M.、Fieschi, C.(1995)。Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)。JAMA，274，1017-1025。 | | 3. | Clark, W. M.、Wissman, S.、Albers, G. W.、Jhamandas, J. H.、Madden, K. P.、Hamilton, S.(1999)。Recombinant tissuetype plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke。JAMA，282，2019-2026。 | | 4. | Adams, H. P. Jr.、Adams, R. J.、Brott, T.、del Zoppo, G. J.、Furlan, A.、Goldstein, L. B.、Grubb, R. L.、Higashida, R.、Kidwell, C.、Kwiatkowski, T. G.、Marler, J. R.、Hademenos, G. J.(2003)。Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association。Stroke，34，1056-1083。 | | 5. | Adams, H. P. Jr.、del Zoppo, G.、Alberts, M. J.(2007)。Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists。Stroke，38，1655-1711。 | | 6. | Wong, W. J.、Hu, H. H.、Lukl, Y. O.、Cherng, C. M.、Lien, L. M.、Chen, J. R.、Chiu, H. C.、Ann, M. Y.、Jong, G. P.、Kuo, T. H.、Chang, K. C.、Tan, T. Y.、Liou, C. W.(2001)。Intravenous thrombolytic therapy in acute ischemic stroke in Taiwan。Taiwan Crit. Care Med，3，112-120。 | | 7. | Wahlgren, N.、Ahmed, N.、Dávalos, A.、Ford, G. A.、Grond, M.、Hacke, W.、Hennerici, M. G.、Kaste, M.、Kuelkens, S.、Larrue, V.、Lees, K. R.、Roine, R. O.、Soinne, L.、Toni, D.、Vanhooren, G.、SITS-MOST investigators(2007)。Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) : an observational study。Lancet，369，275-282。 | | 8. | Lees, K. R.、Bluhmki, E.、Von Kummer, R.(2010)。Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials。Lancet，375，1695-1703。 | | 9. | Chen, W. H.、Lin, H. S.、Chen, C. I.、Chou, M. S.、Liou, C. W.、Chen, S. S.(2011)。Stroke Center-CGMH/Kaohsiung. The medicolegal issue of tissue plasminogen activator in ischemic stroke: a review of judiciary decrees in Taiwan。Acta Neurol Taiwan，20，163-171。 | 其他| 1. | 臺灣腦中風學會rt-PA使用規範共識小組。靜脈血栓溶解劑治療急性缺血性腦中風之一般準則，http://www.stroke.org.tw/guideline/guideline_3.asp。 延伸查詢 | |